Cassava Sciences Inc vs NetApp Inc. — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while NetApp Inc. trades at $199.84 (market cap $38.95B). The key difference: NetApp Inc. is far larger — about 815.7× Cassava Sciences Inc's market cap, and NetApp Inc. pays a 1.05% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | NTAP | |
|---|---|---|
Market Cap | $47.75M | $38.95B |
Sector | Health | Technology |
52-Week High | $4.64 | $198.72 |
52-Week Low | $0.87 | $94.11 |
Enterprise Value | -$34.93M | $38.10B |
Dividend Yield | — | 1.05% |
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →